DORA PSI | Digital Object Repository at PSI

Export As:

Style

Style

Search Results 1 - 20 of 197

Sort

	Select Page
	Terbium-149 production: a focus on yield and quality improvement towards preclinical application Favaretto, C., Grundler, P. V., Talip, Z., Köster, U., Johnston, K., Busslinger, S. D., … van der Meulen, N. P. (2024). Terbium-149 production: a focus on yield and quality improvement towards preclinical application. Scientific Reports, 14(1), 3284 (12 pp.). https://doi.org/10.1038/s41598-024-53610-2 Detailed Record Published Version
	First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([<sup>161</sup>Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum Fricke, J., Westerbergh, F., McDougall, L., Favaretto, C., Christ, E., Nicolas, G. P., … Wild, D. (2024). First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([¹⁶¹Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum. European Journal of Nuclear Medicine and Molecular Imaging, 51, 2517-2519. https://doi.org/10.1007/s00259-024-06641-w Detailed Record Published Version
	Development of wide range photon detection system for muonic X-ray spectroscopy Mizuno, R., Niikura, M., Saito, T. Y., Matsuzaki, T., Sakurai, H., Amato, A., … Wang, C. (2024). Development of wide range photon detection system for muonic X-ray spectroscopy. Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 1060, 169029 (14 pp.). https://doi.org/10.1016/j.nima.2023.169029 Detailed Record Published Version Accepted Version
	In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [<sup>177</sup>Lu]Lu-PP-F11N in humans: the lumed phase 0b study Rottenburger, C., Hentschel, M., Fürstner, M., McDougall, L., Kottoros, D., Kaul, F., … Wild, D. (2024). In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [¹⁷⁷Lu]Lu-PP-F11N in humans: the lumed phase 0b study. EJNMMI Research, 14(1), 37 (13 pp.). https://doi.org/10.1186/s13550-024-01101-w Detailed Record Published Version
	Relaxed fibronectin: a potential novel target for imaging endometriotic lesions Trachsel, B., Imobersteg, S., Valpreda, G., Singer, G., Grabherr, R., Ormos, M., … Béhé, M. (2024). Relaxed fibronectin: a potential novel target for imaging endometriotic lesions. EJNMMI Research, 14(1), 17 (11 pp.). https://doi.org/10.1186/s13550-024-01070-0 Detailed Record Published Version
	Design and preclinical evaluation of a novel prostate-specific membrane antigen radioligand modified with a transthyretin binder Vaccarin, C., Mapanao, A. K., Deberle, L. M., Becker, A. E., Borgna, F., Marzaro, G., … Müller, C. (2024). Design and preclinical evaluation of a novel prostate-specific membrane antigen radioligand modified with a transthyretin binder. Cancers, 16(7), 1262 (13 pp.). https://doi.org/10.3390/cancers16071262 Detailed Record Published Version
	Liquid chromatography ICP-MS to assess the stability of <sup>175</sup>Lu- and <sup>nat</sup>Ga-based tumor-targeting agents towards the development of <sup>177</sup>Lu- and <sup>68</sup>Ga-labeled radiopharmaceuticals Wallimann, R. H., Hensinger, H., Müller, C., Schibli, R., Kneuer, R., & Schindler, P. (2024). Liquid chromatography ICP-MS to assess the stability of ¹⁷⁵Lu- and ^natGa-based tumor-targeting agents towards the development of ¹⁷⁷Lu- and ⁶⁸Ga-labeled radiopharmaceuticals. Pharmaceutics, 16(3), 299 (13 pp.). https://doi.org/10.3390/pharmaceutics16030299 Detailed Record Published Version
	A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides Beyer, D., Vaccarin, C., Deupi, X., Mapanao, A. K., Cohrs, S., Sozzi-Guo, F., … Müller, C. (2023). A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides. EJNMMI Research, 13(1), 32 (14 pp.). https://doi.org/10.1186/s13550-023-00979-2 Detailed Record Published Version
	The non-destructive investigation of a late antique knob bow fibula (Bügelknopffibel) from Kaiseraugst/CH using Muon Induced X-ray Emission (MIXE) Biswas, S., Megatli-Niebel, I., Raselli, L., Simke, R., Cocolios, T. E., Deokar, N., … Amato, A. (2023). The non-destructive investigation of a late antique knob bow fibula (Bügelknopffibel) from Kaiseraugst/CH using Muon Induced X-ray Emission (MIXE). Heritage Science, 11, 43 (17 pp.). https://doi.org/10.1186/s40494-023-00880-0 Detailed Record Published Version
	Investigations using albumin binders to modify the tissue distribution profile of radiopharmaceuticals exemplified with folate radioconjugates Busslinger, S. D., Becker, A. E., Vaccarin, C., Deberle, L. M., Renz, M. L., Groehn, V., … Müller, C. (2023). Investigations using albumin binders to modify the tissue distribution profile of radiopharmaceuticals exemplified with folate radioconjugates. Cancers, 15(17), 4259 (19 pp.). https://doi.org/10.3390/cancers15174259 Detailed Record Published Version
	<sup>161</sup>Tb-DOTATOC production using a fully automated disposable cassette system: a first step toward the introduction of <sup>161</sup>Tb into the clinic Favaretto, C., Grundler, P. V., Talip, Z., Landolt, S., Sepini, L., Köster, U., … van der Meulen, N. P. (2023). ¹⁶¹Tb-DOTATOC production using a fully automated disposable cassette system: a first step toward the introduction of ¹⁶¹Tb into the clinic. Journal of Nuclear Medicine, 64(7), 1138-1144. https://doi.org/10.2967/jnumed.122.265268 Detailed Record Published Version
	GermanIum array for non-destructive testing (GIANT) setup for muon-induced x-ray emission (MIXE) at the Paul Scherrer Institute Gerchow, L., Biswas, S., Janka, G., Vigo, C., Knecht, A., Vogiatzi, S. M., … Amato, A. (2023). GermanIum array for non-destructive testing (GIANT) setup for muon-induced x-ray emission (MIXE) at the Paul Scherrer Institute. Review of Scientific Instruments, 94(4), 045106 (15 pp.). https://doi.org/10.1063/5.0136178 Detailed Record Published Version
	Targeting mTORC1 activity to improve efficacy of radioligand therapy in cancer Grzmil, M., Wiesmann, F., Schibli, R., & Behe, M. (2023). Targeting mTORC1 activity to improve efficacy of radioligand therapy in cancer. Cancers, 15(1), 17 (12 pp.). https://doi.org/10.3390/cancers15010017 Detailed Record Published Version
	An arrowhead made of meteoritic iron from the late Bronze Age settlement of Mörigen, Switzerland and its possible source Hofmann, B. A., Bolliger Schreyer, S., Biswas, S., Gerchow, L., Wiebe, D., Schumann, M., … Amato, A. (2023). An arrowhead made of meteoritic iron from the late Bronze Age settlement of Mörigen, Switzerland and its possible source. Journal of Archaeological Science, 157, 105827 (10 pp.). https://doi.org/10.1016/j.jas.2023.105827 Detailed Record Published Version Supplemental Material Supplemental Material Supplemental Material Supplemental Material
	Detecting radio- and chemoresistant cells in 3D cancer co-cultures using chromatin biomarkers Pekeč, T., Venkatachalapathy, S., Shim, A. R., Paysan, D., Grzmil, M., Schibli, R., … Shivashankar, G. V. (2023). Detecting radio- and chemoresistant cells in 3D cancer co-cultures using chromatin biomarkers. Scientific Reports, 13(1), 20662 (14 pp.). https://doi.org/10.1038/s41598-023-47287-2 Detailed Record Published Version
	Signaling network response to <em>α</em>-particle–targeted therapy with the <sup>225</sup>Ac-labeled minigastrin analog <sup>225</sup>Ac-PP-F11N reveals the radiosensitizing potential of histone deacetylase inhibitors Qin, Y., Imobersteg, S., Frank, S., Blanc, A., Chiorazzo, T., Berger, P., … Grzmil, M. (2023). Signaling network response to α-particle–targeted therapy with the ²²⁵Ac-labeled minigastrin analog ²²⁵Ac-PP-F11N reveals the radiosensitizing potential of histone deacetylase inhibitors. Journal of Nuclear Medicine, 64(6), 873-879. https://doi.org/10.2967/jnumed.122.264597 Detailed Record Published Version
	Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK Trachsel, B., Valpreda, G., Lutz, A., Schibli, R., Mu, L., & Béhé, M. (2023). Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK. EJNMMI Radiopharmacy and Chemistry, 8(1), 21 (11 pp.). https://doi.org/10.1186/s41181-023-00206-2 Detailed Record Published Version
	Albumin-binding and conventional PSMA ligands in combination with <sup>161</sup>Tb: biodistribution, dosimetry, and preclinical therapy Tschan, V. J., Busslinger, S. D., Bernhardt, P., Grundler, P. V., Zeevaart, J. R., Köster, U., … Müller, C. (2023). Albumin-binding and conventional PSMA ligands in combination with ¹⁶¹Tb: biodistribution, dosimetry, and preclinical therapy. Journal of Nuclear Medicine, 64(10), 1625-1631. https://doi.org/10.2967/jnumed.123.265524 Detailed Record Published Version Accepted Version
	Inductively coupled plasma mass spectrometry - a valid method for the characterization of metal conjugates in view of the development of radiopharmaceuticals Wallimann, R. H., Schindler, P., Hensinger, H., Tschan, V. J., Busslinger, S. D., Kneuer, R., … Schibli, R. (2023). Inductively coupled plasma mass spectrometry - a valid method for the characterization of metal conjugates in view of the development of radiopharmaceuticals. Molecular Pharmaceutics, 20(4), 2150-2158. https://doi.org/10.1021/acs.molpharmaceut.2c01092 Detailed Record Published Version
	Design and evaluation of novel albumin-binding folate radioconjugates: systematic approach of varying the linker entities Benešová, M., Guzik, P., Deberle, L. M., Busslinger, S. D., Landolt, T., Schibli, R., & Müller, C. (2022). Design and evaluation of novel albumin-binding folate radioconjugates: systematic approach of varying the linker entities. Molecular Pharmaceutics, 19, 963-973. https://doi.org/10.1021/acs.molpharmaceut.1c00932 Detailed Record Published Version Accepted Version